Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / AGRX - Nasdaq grants Agile Therapeutics 180-day extension to regain compliance

AGRX - Nasdaq grants Agile Therapeutics 180-day extension to regain compliance

Agile Therapeutics Inc.

  • Nasdaq has granted to the women's healthcare company Agile Therapeutics ( NASDAQ: AGRX ) a 180-day extension to regain compliance with the stock exchange's listing requirements.
  • The company has until Aug. 14 to meet the requirement.
  • The company was notified of its failure to maintain a minimum bid price of $1.00 per share on Aug. 15, 2022.
  • AGRX shares were trading +4.98% pre-market.
  • Source: Press Release

For further details see:

Nasdaq grants Agile Therapeutics 180-day extension to regain compliance
Stock Information
Company Name: Agile Therapeutics Inc.
Stock Symbol: AGRX
Market: OTC
Website: agiletherapeutics.com
Menu
AGRX AGRX Quote AGRX Short AGRX News AGRX Articles AGRX Message Board
Get AGRX Alerts

News, Short Squeeze, Breakout and More Instantly...